XCancer — Omaha, Nebraska

XCancer is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

XCancer has participated in 8 clinical trials with 6 currently active.

Therapeutic areas: Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent.

Sponsors: Clarity Pharmaceuticals Ltd, Radiopharm Theranostics, Ltd, Fusion Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for XCancer?

XCancer has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has XCancer conducted?

XCancer has 8 clinical trials on record, with 6 currently active. Their work covers Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent.

Is XCancer accredited by Crixeo Health?

Yes — XCancer holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about XCancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.